CA2311684A1 - G-csf modifie chimiquement - Google Patents

G-csf modifie chimiquement Download PDF

Info

Publication number
CA2311684A1
CA2311684A1 CA002311684A CA2311684A CA2311684A1 CA 2311684 A1 CA2311684 A1 CA 2311684A1 CA 002311684 A CA002311684 A CA 002311684A CA 2311684 A CA2311684 A CA 2311684A CA 2311684 A1 CA2311684 A1 CA 2311684A1
Authority
CA
Canada
Prior art keywords
leu
ala
gln
ser
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002311684A
Other languages
English (en)
Other versions
CA2311684C (fr
Inventor
Rika Ishikawa
Yuji Okada
Makoto Kakitani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen K A Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from CA002006596A external-priority patent/CA2006596C/fr
Publication of CA2311684A1 publication Critical patent/CA2311684A1/fr
Application granted granted Critical
Publication of CA2311684C publication Critical patent/CA2311684C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002311684A 1988-12-22 1989-12-22 G-csf modifie chimiquement Expired - Lifetime CA2311684C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP324747/88 1988-12-22
JP32474788 1988-12-22
JP199176/89 1989-07-31
JP19917689 1989-07-31
CA002006596A CA2006596C (fr) 1988-12-22 1989-12-22 G-csf modifie chimiquement

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002006596A Division CA2006596C (fr) 1988-12-22 1989-12-22 G-csf modifie chimiquement

Publications (2)

Publication Number Publication Date
CA2311684A1 true CA2311684A1 (fr) 1990-06-22
CA2311684C CA2311684C (fr) 2002-12-10

Family

ID=27168683

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002311684A Expired - Lifetime CA2311684C (fr) 1988-12-22 1989-12-22 G-csf modifie chimiquement

Country Status (1)

Country Link
CA (1) CA2311684C (fr)

Also Published As

Publication number Publication date
CA2311684C (fr) 2002-12-10

Similar Documents

Publication Publication Date Title
IL92853A0 (en) Human insulin analogues,their preparation and pharmaceutical compositions containing them
AU694685B2 (en) Recombinant retroviruses delivering vector constructs to target cells
GR3026553T3 (en) Porcine CNP gene and precursor protein
ES8801674A1 (es) Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
CA2050300A1 (fr) Proteines inhibant le tnf et leur preparation
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
CA2061148A1 (fr) Facteur d'activation de la nevroglie, et sa production
IE850614L (en) Cloning of interleukin
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
CA2062969A1 (fr) Proteine cofacteur de la membrane humaine produite par recombinaison
CA2002924A1 (fr) Antithrombines
DE69201438D1 (en) Als therapeutika geeignete peptide.
AU2308992A (en) Cysteine depleted il-6 muteins
CA2083837A1 (fr) Codage de l'adn recombinant pour une nouvelle proteine ayant une activite de .beta.-1,3-glucanase, bacterie contenant cet adn, cellules vegetales transformees et vegetaux
CA2071757A1 (fr) Compositions pour implant contenant une proteine, un peptide ou un polypeptide biologiquement actif
IL90391A0 (en) Peptides suppressing the function of the immune system,their preparation and pharmaceutical compositions containing them
NZ334714A (en) Liver proteins as agents against autoimmune diseases
CA2077590A1 (fr) Adn recombinant codant pour une proteine reagissant avec l'endochitinase
EP0292257A3 (fr) Peptides à activité d'ANF
CA2311684A1 (fr) G-csf modifie chimiquement
CA2056467A1 (fr) Somatotrophines presentant des alterations dans la region 1 de l'alpha-helice, et combinaisons avec d'autres mutations
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
CA2139571A1 (fr) Peptides fixatrices du recepteur de l'interferon
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
EP0147175A3 (fr) Polypeptides de base et méthode pour leur préparation

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry